Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 122.58M | 153.94M | 165.83M | 147.01M | 145.37M |
Gross Profit | 30.35M | 81.59M | 96.56M | 93.01M | 104.15M |
EBITDA | 48.00M | 48.45M | 62.25M | 64.73M | 59.81M |
Net Income | 2.16M | 1.41M | 11.87M | 10.05M | -655.00K |
Balance Sheet | |||||
Total Assets | 316.99M | 306.07M | 279.52M | 239.73M | 316.13M |
Cash, Cash Equivalents and Short-Term Investments | 71.01M | 6.26M | 2.03M | 10.55M | 5.50M |
Total Debt | 130.25M | 150.28M | 110.24M | 77.05M | 192.40M |
Total Liabilities | 173.57M | 178.71M | 154.67M | 126.76M | 228.89M |
Stockholders Equity | 143.42M | 127.36M | 124.85M | 112.98M | 87.24M |
Cash Flow | |||||
Free Cash Flow | 32.47M | 16.06M | 33.41M | 45.97M | 45.89M |
Operating Cash Flow | 32.88M | 17.34M | 36.59M | 47.58M | 46.32M |
Investing Cash Flow | 254.00K | -1.27M | -34.11M | -1.07M | 4.84M |
Financing Cash Flow | -38.27M | -16.05M | -14.20M | -81.53M | -85.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | HK$2.26T | 5.91 | 10.81% | 10.47% | -3.79% | -0.62% | |
79 Outperform | HK$65.39B | 13.98 | 25.49% | 4.64% | -3.11% | 15.29% | |
72 Outperform | $127.10B | 13.45 | 4.26% | 3.49% | -36.59% | ― | |
71 Outperform | HK$10.14B | 7.72 | 4.75% | 3.81% | 4.24% | 25.30% | |
68 Neutral | $123.40B | 65.03 | 6.14% | 1.16% | 7.63% | -24.23% | |
65 Neutral | $10.94B | 15.63 | 5.18% | 1.91% | 3.14% | -27.13% | |
53 Neutral | HK$88.08M | ― | -2.40% | ― | -35.83% | -145.21% |